RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Wall St
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia [Yahoo! Finance]
Form 8-K REVIVA PHARMACEUTICALS For: Dec 18
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Funtleyder Leslie D.
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Patel Purav
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Margolin Richard A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.